A detailed history of Dmg Group, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Dmg Group, LLC holds 13,883 shares of LQDA stock, worth $152,851. This represents 0.11% of its overall portfolio holdings.

Number of Shares
13,883
Previous 10,158 36.67%
Holding current value
$152,851
Previous $121,000 14.05%
% of portfolio
0.11%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$8.9 - $14.11 $33,152 - $52,559
3,725 Added 36.67%
13,883 $138,000
Q2 2024

Jul 16, 2024

BUY
$11.96 - $15.71 $121,489 - $159,582
10,158 New
10,158 $121,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Dmg Group, LLC Portfolio

Follow Dmg Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.